Table 4.
Phenotypic analysis of KIR expression on CD56+ cells of HLA-matched donors used as effector cells in Figure 3C-D
|
% CD56+
|
|||||
|---|---|---|---|---|---|
| Donor | HLA-Cw | HLA-C group | KIR2DL1 | KIR2DL2 | KIR2DL2/KIR2DL1 ratio |
| Patient 4 | 03/07 | 1/1 | 7 | 10 | 1.4 |
| Patient 5 | 04/15 | 2/2 | 8 | 4.5 | 0.6 |